{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:56:32Z","timestamp":1794491792443,"version":"4.9.1"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Auxotrophic mutants of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    have been proposed as new vaccine candidates. We have analyzed the virulence and vaccine potential of\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    strains containing defined mutations in genes involved in methionine (\n                    <jats:italic>metB<\/jats:italic>\n                    ), proline (\n                    <jats:italic>proC<\/jats:italic>\n                    ), or tryptophan (\n                    <jats:italic>trpD<\/jats:italic>\n                    ) amino acid biosynthesis. The\n                    <jats:italic>metB<\/jats:italic>\n                    mutant was a prototrophic strain, whereas the\n                    <jats:italic>proC<\/jats:italic>\n                    and\n                    <jats:italic>trpD<\/jats:italic>\n                    mutants were auxotrophic for proline and tryptophan, respectively. Following infection of murine bone marrow-derived macrophages, H37Rv and the\n                    <jats:italic>metB<\/jats:italic>\n                    mutant strain survived intracellularly for over 10 days, whereas over 90% of\n                    <jats:italic>proC<\/jats:italic>\n                    and\n                    <jats:italic>trpD<\/jats:italic>\n                    mutants were killed during this time. In SCID mice, both H37Rv and the\n                    <jats:italic>metB<\/jats:italic>\n                    mutant were highly virulent, with mouse median survival times (MST) of 28.5 and 42 days, respectively. The\n                    <jats:italic>proC<\/jats:italic>\n                    mutant was significantly attenuated (MST, 130 days), whereas the\n                    <jats:italic>trpD<\/jats:italic>\n                    mutant was essentially avirulent in an immunocompromised host. Following infection of immunocompetent DBA mice with H37Rv, mice survived for a median of 83.5 days and the\n                    <jats:italic>metB<\/jats:italic>\n                    mutant now showed a clear reduction in virulence, with two of five infected mice surviving for 360 days. Both\n                    <jats:italic>proC<\/jats:italic>\n                    and\n                    <jats:italic>trpD<\/jats:italic>\n                    mutants were avirulent (MST of &gt;360 days). In vaccination studies, prior infection with either the\n                    <jats:italic>proC<\/jats:italic>\n                    or\n                    <jats:italic>trpD<\/jats:italic>\n                    mutant gave protection equivalent (\n                    <jats:italic>proC<\/jats:italic>\n                    mutant) to or better (\n                    <jats:italic>trpD<\/jats:italic>\n                    mutant) than BCG against challenge with\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    H37Rv. In summary,\n                    <jats:italic>proC<\/jats:italic>\n                    and\n                    <jats:italic>trpD<\/jats:italic>\n                    genes are essential for the virulence of\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    , and mutants with disruptions in either of these genes show strong potential as vaccine candidates.\n                  <\/jats:p>","DOI":"10.1128\/iai.69.2.1442-1150.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:01:19Z","timestamp":1027749679000},"page":"1142-1150","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":216,"title":["Characterization of Auxotrophic Mutants of\n                    <i>Mycobacterium tuberculosis<\/i>\n                    and Their Potential as Vaccine Candidates"],"prefix":"10.1128","volume":"69","author":[{"given":"Debbie A.","family":"Smith","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Parish","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil G.","family":"Stoker","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Bancroft","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-679X(08)61849-X"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.5.1794-1799.1996"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/31159"},{"key":"e_1_3_2_5_2","unstructured":"Davis P. D. O. Clinical tuberculosis 2nd ed. Chapman & Hall Medical London United Kingdom."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3428-3437.1995"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.677"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(99)01549-2"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.14.5189"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92348-9"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(83)90038-7"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0396-334"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.8.1299"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/291238a0"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.5.2888-2898.2000"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.2867-2873.1999"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.24.11470"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.178.5.1274-1282.1996"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.3.1004-1012.1995"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00419.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.6.1449-1455.1988"},{"key":"e_1_3_2_22_2","first-page":"1959","article-title":"Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ","volume":"142","author":"North R. J.","year":"1993","unstructured":"North R. J. Izzo A. A. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ.Am. J. Pathol.142199319591966","journal-title":"Am. J. Pathol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1723"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.2.419-423.1988"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806043382301"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-145-12-3497"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-146-8-1969"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8479(97)90016-2"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.8.3048-3056.1997"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00384.x"},{"key":"e_1_3_2_31_2","first-page":"142","article-title":"Differential identification of mycobacteria. Use of thiacetazone, thiophen-2-carboxylic acid hydrazide and tripheyltetrazolium chloride","volume":"48","author":"Vestal A. L.","year":"1967","unstructured":"Vestal A. L. Kubica G. P. Differential identification of mycobacteria. Use of thiacetazone, thiophen-2-carboxylic acid hydrazide and tripheyltetrazolium chloride.Scand. J. Respir. Dis.481967142148","journal-title":"Scand. J. Respir. Dis."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/145.3.292"},{"key":"e_1_3_2_33_2","unstructured":"Young\nD. B.\nFruth\nU.\nNew vaccines against tuberculosis\nNew generation vaccines.\nLevine\nM.\nWoodrow\nG.\nKaper\nJ.\nCobon\nG. S.\n1997\n631\n645\nMarcel Dekker\nNew York N.Y"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.2.1442-1150.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.2.1442-1150.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T21:02:36Z","timestamp":1646427756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.2.1442-1150.2001"}},"subtitle":[],"editor":[{"given":"J. D.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1128\/IAI.69.2.1442-1150.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.2.1442-1150.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"2000-09-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-11-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}